Antimitochondrial antibodies are markers for primary biliary cirrhosis and probably reflect a specific d e f e in immunoregulation underlying this disease. Antimitochondrial antibodies and their primary biliary cirrhods-epecific subtypes were tested before and up to 6 y m after orthotopic liver tra
Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation
โ Scribed by Reinhild Klein; Johannes R. Huizenga; Chris H. Gips; Peter A. Berg
- Book ID
- 118566113
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 664 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
rum. 1 In the past decade, two treatment modalities have Approximately 5% to 10% of patients with features otherbeen shown to be effective in the treatment for PBC, dewise consistent with primary biliary cirrhosis (PBC) lack antipending on the stage of the disease. For patients with less mitochondri
The presence of antimitochondrial antibodies (AMA) is a major criterion for the diagnosis of primary biliary cirrhosis (PBC). Although it is not clear that AMA are involved in the pathogenesis of the disease, the study of these autoantibodies has enabled much information to be accumulated about the